Lumpers vs Splitters: Categorizing Prostate Cancer
Should very low-risk and low-risk be combined into one?
Stay updated with breaking news from Daniel Spratt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Should very low-risk and low-risk be combined into one?
Findings represent first validation of any gene expression biomarker for intermediate-risk patients using data from a randomized phase 3 clinical trial ... | May 2, 2023
/PRNewswire/ -- The Urology Care Foundation, the world's leading nonprofit urological health foundation and official foundation of the American Urological...
Doctors across the United States who treat people with advanced prostate cancer can't find supplies of a medicine that may help them live longer.
/PRNewswire/ -- RaySearch Laboratories AB (publ) announces that University Hospitals Seidman Cancer Center/Case Western Reserve University in Cleveland, Ohio,...